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Methodological issues in studying the epidemiology of mild tions as they relate to (1) defining the prevalence of mild
to moderate chronic renal insufficiency. There is increasing to moderate CRI, (2) examining mild to moderate CRI
interest in studying the epidemiology of subjects with mild to as an outcome, and (3) examining mild to moderate CRImoderate chronic renal insufficiency (CRI), defined as reduced
as an exposure (Table 1).glomerular filtration rate (GFR) not requiring renal replace-
ment therapy. This review discusses some of the methodologi-
Glomerular filtration rate, serum creatininecal challenges presented by the epidemiological study of mild
to moderate CRI that have not been adequately addressed in concentration and creatinine clearance
the literature. Issues that relate to defining the prevalence of Glomerular filtration rate (GFR) is generally acceptedCRI include between-laboratory differences in serum creati-
as the best overall index of renal function. Gold standardnine (SCr) assays, within-person measurement errors in SCr, and
measures of GFR include inulin and iothalamate clear-differences in SCr in different demographic groups that are
independent of GFR. Issues that relate to examining CRI as an ance. As discussed later, there is substantial day-to-day
outcome include the choice between a “slope” or “threshold” variation in measured GFR. Conceptually, it is the aver-
analysis. Issues that relate to examining CRI as an exposure age GFR over days to weeks that defines the severity ofinclude the choice of renal function measure (for example,
CRI since it is presumably this average GFR that bestSCr vs. estimated GFR) in multivariable analysis, whether to
predicts adverse outcomes (for example, degree of ane-normalize renal function to body surface area or other body
size parameters, potential effect modification of the association mia, blood pressure elevation).
between CRI and the outcome and the complex relation be- However, given its simplicity, low cost, and widespread
tween CRI, adverse outcomes, potential confounders and inter- use, serum creatinine has been relied upon as the princi-mediary variables. As we enter an era of more intensive study
pal indicator of renal function in epidemiological studies,of mild to moderate CRI, recognition of these potential pitfalls
and will likely remain so for the foreseeable future.should guide researchers toward improving the quality of epi-
demiological research in this field. The complex relationships between serum creatinine
concentration (SCr), GFR, tubular secretion of creatinine
(TSCr) and renal creatinine excretion (UCrV) can be sum-
There is increasing interest in studying the epidemiol- marized by the following equation [18, 19]:
ogy of subjects with mild to moderate chronic renal insuf-
SCr  (UCrV  TSCr)/GFR (Eq. 1)ficiency (CRI), defined as reduced glomerular filtration
rate (GFR) not requiring renal replacement therapy [1]. For the sake of simplicity, unless otherwise specified,
Recent surveys have shown that mild to moderate CRI we will ignore extrarenal clearance of creatinine and
is common [2, 3] and is associated with a variety of assume that renal creatinine excretion, UCrV, is equal to
homeostatic abnormalities and adverse clinical conse- creatinine generation, both endogenous and exogenous.
quences [4–17]. This relatively new area of research pre- Creatinine clearance (CCr) is greater than the GFR
sents several methodological challenges that have not because of tubular secretion of creatinine.
been adequately addressed in the literature. This article
CCr  (UCrV)/SCr  GFR  (TSCr/SCr) (Eq. 2)will discuss some of these issues and their potential solu-
Equations such as Cockcroft-Gault [20] estimate CCr
by estimating UCrV using age, sex and weight since theseKey words: chronic kidney disease, prevalence, incidence, exposure,
outcome, analysis. correlate with muscle mass and the endogenous genera-
tion of creatinine.Received for publication April 11, 2001
and in revised form September 25, 2001 Cockcroft-Gault CCr (mL/min)  [(140  age)Accepted for publication October 1, 2001
 2002 by the International Society of Nephrology * weight (* 0.85 if female)/72]/SCr (Eq. 3)
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Table 1. Methodological issues and proposed solutions for studying the epidemiology of mild to moderate chronic renal insufficiency (CRI)
Topic Methodological issues Proposed solutions
Defining the prevalence of CRI Between-laboratory differences in serum Standardize assays
creatinine (SCr) assays
Report details of SCr assay (e.g., the upper bounds
of the “normal reference range”)
Within-person measurement errors in SCr Repeat measures of SCr at least twice in a subset
of subjects
Differences in SCr in different demographic Interpret SCr as reflection of GFR in context of
groups that are independent of GFR differences in creatinine generation and tubular
secretion by age, sex and race
Examining CRI as an outcome Choice of “slope” vs. “threshold” analysis Justify choice and understand assumptions under-
lying slope or threshold analyses
Consider a slope analysis to explore mechanisms
for progression of CRI; consider a threshold
analysis to assess the public health impact of CRI
Examining CRI as an exposure Choice of renal function measure to use in Use estimated CCr or GFR to represent severity of
multivariable analysis CRI, rather than SCr alone
Use unbiased categories of estimated CCr or GFR
and avoid assumption of linearity
Whether or not to normalize measures of Perform analyses using both normalized and non-
renal function to body surface area or normalized measures and compare results
other body size parameters
Use non-normalized values if normalization
parameter is independently associated with
outcome of interest
Potential effect modification of the associa- Explore potential effect modification by demo-
tion between CRI and outcome graphic and clinical factors
Complex relation between CRI, adverse Collect longitudinal data and conduct longitudinal
outcomes, potential confounders and analysis
intermediary variables
Conduct analysis with and without adjustment for
factors that are both potential confounders and
intermediary variables
Designate intermediary variables as being present
before or after known CRI (i.e., prevalent vs.
incident co-factors)
GFR is glomerular filtration rate.
Recently, considerable attention has been paid to a DEFINING THE PREVALENCE OF
MILD TO MODERATE CHRONICnew formula published by the Modification of Diet in
RENAL INSUFFICIENCYRenal Disease (MDRD) study that estimates GFR from
demographic and laboratory variables [21]: Lack of standardization in assays of serum
creatinine concentration
MDRD GFR (mL/min/1.73 m2)  170
One important limitation of applying SCr in an assess-
* [SCr]0.999 * [age]0.176 ment of renal function is between-laboratory differences
in the measurement of SCr, which can be as large as* [BUN]0.170 * [albumin]0.318 0.3 mg/dL [22]. For example, one study found that in
the range of SCr 1.0 mg/dL to 4.0 mg/dL, the Hitachi* [0.762 if female] * [1.180 if black] (Eq. 4)
736 analyzer (Boehringer Mannheim, Indianapolis, IN,
The implications of these relationships and estima- USA) consistently gave readings that were 0.2 mg/dL
tions in epidemiological studies of CRI are discussed higher than the CX3 analyzer (Beckman Instruments,
Brea, CA, USA) [23].later in this article.
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The lack of uniformity in measuring SCr makes it dif-
ficult to compare reported disease prevalence across
studies. According to National Health and Nutrition
Examination Survey (NHANES) III data, 5% of U.S.
non-Hispanic white women aged 40 to 59 years had a SCr
over 1.15 mg/dL [2]. In contrast, 8% of the Framingham
cohort women (mostly white, mean age 55) had SCr values
over 1.4 mg/dL [24]. One cannot conclude that there is
a several-fold higher prevalence of mild to moderate
CRI among the women of Framingham, Massachusetts
until it is known how much of the observed difference
is due to differences in SCr measurement. The SCr analysis
in NHANES III was performed by the modified kinetic
Jaffe reaction using a Hitachi 737 analyzer [2], while SCr
Fig. 1. Effect of within-person measurement error on determining thevalues in Framingham were “determined by either the percent of a population with serum creatinine (SCr) above a certain cutoff.
autoanalyzer technique or the creatinine imodohydro- Dashed line represents observed distribution, solid line represents true
population distribution, and hatched area represents observed percentlase assay” [24].
of population with elevated SCr (for example, 1.4 mg/dL); (shadedWe conclude that standardization of SCr measurement area) true population percent.
is clearly needed. Until that occurs, details of the assay
used should be provided in all published works (for ex-
ample, the upper bounds of the “normal reference range”).
and methodology and has been reported to range fromImproved standardization of SCr assays should focus par-
1% [2] to 11% [19].ticularly on the lower ranges of SCr, since a fixed bias
The second source of error comes from the day-to-will have a greater effect in patients with lower SCr (such
day fluctuations in SCr due to real short-term fluctuationsas, 20% for a bias of 0.2 mg/dL when SCr is 1.0 mg/dL
in renal function, such as what might be expected due tovs. 5% when SCr is 4.0 mg/dL).
changes in extracellular volume, time of day and postureThis systematic bias problem persists when SCr is used
[27, 28]. A recent study that re-measured GFR in theto estimate CCr or GFR in the Cockcroft-Gault equation
same individuals within seven to 28 days showed that the[20] or the MDRD formula [21]. Many studies that com-
between-day coefficient of variation in measured GFRpared the performance of these formulas to gold stan-
ranged from 12% to 17% [29]. Since it is the averagedard measurements (such as, iothalamate clearance) used
renal function over days to weeks that is the physiologicalcorrelation coefficients [25]. The correlation coefficient
variable of interest, these short-term fluctuations in renalmeasures the strength of a relation between two vari-
function can be considered as “errors” when determining
ables, not the agreement in absolute value [26]. If there the true population prevalence.
is a systematic bias in SCr of, for example, 0.1 mg/dL, all To illustrate the effect of within-person measurement
derived CCr and GFR estimates will be systematically error on determining the percent of a population with
biased. The correlation coefficient is an insensitive mea- SCr above a certain cutoff, a hypothetical example is used
sure of this bias. Since investigators are interested in both in which, for simplicity, we assume that the distribution
the comparative and absolute levels of renal function, of the observed values of SCr in the target population is
correlation with and the absolute and percent differences normally distributed with a mean SCr 1.0 mg/dL and a
from the gold standard also should be evaluated [23, 26]. standard deviation of 0.2 mg/dL (Fig. 1). Based on the
observed standard deviation of 0.2 mL/dL, which reflects
Within-person measurement error of serum creatinine both true variability and measurement error in SCr, 2.3%
Published studies of the distribution of SCr in a given of subjects would be estimated to have SCr values above
1.4 mg/dL (which is two standard deviations above thepopulation have used a single determination per person
mean). What is the true population prevalence of SCr[2, 24]. Owing to within-person variation, the observed
1.4 mg/dL if the standard deviation for repeat SCr mea-standard deviation will be larger than the true population
surements with the same patient is assumed to be 0.1standard deviation, resulting in overestimation of the
mg/dL (10% of the mean SCr of 1.0 mg/dL)?number of subjects with SCr above a certain level.
Since,The first source of within-person measurement error
is random error from the assay itself (that is, variations Observed population variance
in the assay result if the same sample were measured re-
 True population variancepeatedly). The coefficient of variation (ratio of standard
deviation to mean) for this depends on the absolute SCr  Within-person variance (Eq. 5)
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(Observed population standard deviation)2
 (True population standard deviation)2
 (Within-person standard deviation)2 (Eq. 6)
True population standard deviation
 (0.04  0.01)1⁄2  0.17 mg/dL (Eq. 7)
After correcting for the within-person measurement
error, a SCr of 1.4 mg/dL would actually be 2.4 (0.4/0.17)
standard deviations above the mean. The true population
prevalence after correcting for the within-person mea-
surement error is 0.9%, which is substantially lower than
Fig. 2. Creatinine distribution in the United States by gender, accordingthe original 2.3% estimate.
to the NHANES III Study, 1988 to 1994. Percent distribution is plottedIn conclusion, repeated measurements of SCr are nec- separately for () males and () females aged 12 years or older. Sample
essary to correct for within-person measurement error, values were weighted to estimate the distribution of creatinine values
in the U.S. population by age, ethnicity, and sex. Reproduced withbut these need to be performed only in a subset of sub-
permission from the National Kidney Foundation [2].jects. Based on an evaluation of the within-person vari-
ability in SCr, it is possible to use statistical adjustment
techniques to estimate the true population distribution
from the observed distribution of SCr. (However, it should
Differences in distribution of serum creatinine bybe noted that in real applications somewhat sophisticated
demographic factorsstatistical techniques would be needed to take into ac-
count the non-normality of the distribution of SCr in most Age and gender differences. Persons with the same SCr
populations (Fig. 2), and the general observation that can have very different underlying GFR values, because
the within-patient standard deviation in SCr is larger for of substantial between-person differences in daily creati-
patients with higher SCr values.) nine generation (UCrV) by gender and age.
Therefore, it may be inappropriate to use the same SCr
Implications for enrollment and follow-up of CRI cutoff to define the prevalence of mild or moderate CRI
cohort studies irrespective of gender (and age). One study using data
The fact that a person’s observed SCr (and GFR) can is from NHANES II suggested that more than twice as
change upon repeat measurement within a short time many U.S. males as females (310,000 vs. 130,000) suffered
period has implications for the design and interpretation from “predialysis renal insufficiency,” defined therein as
of cohort studies of subjects with CRI. a SCr value of 2.1 to 8.0 mg/dL [30]. Another study found
Random misclassification of renal function at entry a “marked preponderance of males” (64% vs. 36% fe-
will result in the enrollment of some subjects whose aver- males) with “moderate but established” renal insuffi-
age GFR over days to weeks is actually above the study ciency defined as SCr 200 mol/L (2.3 mg/dL) [31].
cutoff. This problem can be minimized by basing the entry Some of the observed difference by gender is due to the
fact that many women with reduced GFR do not gener-criteria on more than one measurement of renal function.
During follow-up, random misclassification leads to un- ate enough creatinine to reach a certain SCr threshold.
Racial differences. Data from NHANES III show thatderestimation of the strength of association. Statistical
methods exist to adjust for this “regression dilution bias.” within any given age and sex stratum, SCr levels are higher
among blacks than whites. For example, for non-HispanicSystematic misclassification, such as that resulting
from screening and enrolling subjects from different cen- black men aged 40 to 59 years, the median, mean, and
95th percentile values for SCr were 1.17 mg/dL, 1.28 mg/dL,ters using the same SCr threshold without standardization
of SCr assays, will lead to systematic biases in enrollment and 1.55 mg/dL, and for non-Hispanic white men 1.11
mg/dL, 1.16 mg/dL and 1.36 mg/dL [2]. The reason forand effect estimation. Use of a centralized laboratory is
obviously necessary in these cases. this racial difference is unknown. Higher SCr may be
the result of (i) lower GFR, (ii) lower renal TSCr, (iii)Random and systematic misclassification of renal func-
tion not only bias estimates of CRI prevalence, but also increased generation of creatinine (UCrV), or some com-
bination thereof. There is evidence to support all threeaffect the enrollment and follow-up of CRI subjects in
epidemiological studies. These issues also need to be ad- possibilities.
(i) The 3:1 ratio of the percent of non-Hispanic blackdressed through repeated measurements and assay stan-
dardization. and non-Hispanic white persons with SCr values of 2.0
Hsu et al: Epidemiology of mild to moderate CRI 1571
mg/dL estimated in NHANES III is consistent with the subjects had a mean decrease of 0.001  0.004 mg/dL
(P  0.004) [37]. The authors concluded that blacks3:1 ratio of the incidence rates of end-stage renal disease
(ESRD) of black and white persons in the United States are more likely to develop hypertension-induced renal
injury. An alternative hypothesis is that blacks and whites[2]. This argues that higher SCr values reflect decreased
GFRs among black subjects. experienced similar declines in GFR, but the change
in SCr was masked in whites because of compensatory(ii) Some data suggest that at any given level of GFR,
black subjects have a lower rate of TSCr than whites. increases in creatinine secretion [34], or changes in cre-
atinine generation.In the African-American Study of Kidney Disease and
Hypertension (AASK) Pilot Study, the ratios of CCr to More longitudinal studies are needed to understand
how changes in SCr over time relate to changes in CCrGFR were only 1.01, 1.02, 1.13 and 1.21 at GFRs of
80–99, 60–79, 40–59 and 20–39 mL/min/1.73 m2, respec- and GFR [32]. Measurements of SCr, CCr and GFR should
be made in the same subjects at the same time points.tively [23]. Thus, the overestimation of GFR by CCr ap-
pears to be substantially less than previously reported This way, how SCr changes over time relative to GFR (and
CCr) and how this relationship varies by demographic orin the literature, based on studies of mostly white subjects
[23, 32–34]. For example, Shemesh et al determined that clinical features, level of GFR or the type of underlying
renal disease (for example, glomerular vs. tubulointer-ratios of CCr to GFR were 1.57 and 1.91 at GFR 40–80
and 40 mL/min [34]. stitial) can be determined.
(iii) Some researchers have found that black subjects
Slope versus threshold analysishave higher renal creatinine excretion per kilogram body
weight than whites, possibly related to differences in body Observational cohort studies that examine mild to mod-
composition, muscle metabolism, or diet [35]. This sug- erate CRI as an outcome can be divided into those that
gests that greater creatinine generation (per kg body used a “slope” analysis and those that used a “threshold”
weight) may contribute to the higher SCr observed. analysis.
In conclusion, sex-, age-, and race-specific SCr cut- Slope analysis cohort studies use an observed change
points should be used to define the prevalence of CRI in renal function over time as the outcome of interest,
in different demographic subgroups [36]. with the change compared in the exposed versus unex-
posed group. Definitions of slopes that have been used
include rate of change of SCr [38], rate of change ofEXAMINING MILD TO MODERATE CHRONIC reciprocal SCr [37], rate of change of measured CCr [39],RENAL INSUFFICIENCY AS AN OUTCOME and rate of change of measured GFR [40]. Even more
Racial differences complex outcome variables have included the ratio of
the SCr after three years of follow-up divided by theThe possibility that blacks may not have similar in-
baseline SCr [41] and the reciprocal of the follow-up SCrcreases in tubular secretion of creatinine as GFR declines
as a percent of the initial value [42].has important implications. Potential racial differences
Threshold analysis cohort studies use a certain cutoffin UCrV and TSCr must be taken into account when in-
for all subjects to define the development of CRI andterpreting the results of studies using SCr alone to demon-
then compare the number of new cases in the exposedstrate race-specific effects of certain exposures on renal
and unexposed groups. The cutoffs can be either SCrfunction.
values [43, 44] or SCr-derived clearance estimations [3].In the Hypertension Detection and Follow-up Pro-
The combination of a slope analysis with a threshold hasgram, the baseline mean SCr for white men was 1.15
been applied (such as, estimated CCr decline of2.5 mL/mg/dL, black men 1.22 mg/dL, white women 0.92 mg/dL,
min/year and falling below 60 mL/min) [3].and black women 1.00 mg/dL [12]. Twice as many blacks
The choice of slope versus threshold analysis has re-as whites developed “clinically significant hypercreati-
ceived scant attention (abstract; Greene T et al, Contninemia”, defined as fifth-year SCr2.0 mg/dL and1.25
times baseline values [12]. Interpreting this risk ratio is Clin Trials 16:65S, 1995), but it has important implica-
tions. This is illustrated by the following hypotheticalcomplicated by differences in baseline SCr and the fact
that there may be racial differences in how decrements study examining the effect of a certain factor on two
groups of subjects, both with a mean baseline SCr of 1.0in GFR are related to increases in SCr.
In a study of hypertensive subjects enrolled in MRFIT mg/dL (and identical distributions). Suppose unexposed
subjects have on average lower creatinine generation(Multiple Risk Factor Intervention Trial), blacks had a
slightly higher baseline SCr compared with whites (1.13 and the SCr of 1.0 mg/dL represents a CCr of 60 mL/min.
In contrast, subjects in the exposed group have highermg/dL vs. 1.10 mg/dL). After six years of follow-up, de-
spite similar blood pressure values, black subjects had a creatinine generation, and their mean CCr is 80 mL/min.
In five years, the mean SCr in both groups of patientsmean increase in SCr of 0.035 0.010 mg/dL, while white
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increases to 1.5 mL/dL. Assuming creatinine generation has the potential disadvantage of exposure misclassifica-
has not changed over time, what is the association of tion since, as discussed earlier, the same SCr can represent
this factor with renal function? different GFRs [12–15, 17, 45]. Some studies have adjusted
Using a slope analysis of 1/creatinine values (0.067 for age and sex and other non-GFR predictors of SCr
dL/mg/year), researchers can conclude that both groups in multivariable analysis. If all the important non-GFR
have lost equal amounts of renal function and the factor predictors of SCr are adjusted for in the model together
is not associated with risk of CRI. However, since the with SCr, then exposure misclassification due to differ-
CCr of unexposed patients decreased from 60 mL/min to ences in creatinine generation is reduced and differences
40 mL/min (CCr slope 4 mL/min/year) and that of exposed in SCr should reflect mostly differences in GFR.
patients from 80 mL/min to 53 mL/min (5.3 mL/min/ In studies where SCr was treated as a continuous vari-
year), others would conclude that exposure increases the able [15], then a change in SCr from 1 to 2 mg/dL wasrisk of CRI. In contrast, if the outcome were defined as assumed to confer the same incremental risk as a change
falling below an absolute CCr threshold of 50 mL/min, in SCr from 2 to 3 mg/dL. However, this assumption maythen the conclusion could be that exposure decreases
not hold.the risk of CRI.
Using Cockcroft-Gault equation estimated CCr or MDRDIn other words, very different conclusions may be drawn
formula estimated GFR to classify renal function. Thisfrom the same data depending on the definition of out-
reduces misclassification of renal function compared tocome and the choice of slope versus threshold analysis.
using SCr alone and there is a more intuitive interpreta-Hence, researchers should justify their choice of slope
tion of the renal function term, now in mL/min of CCror threshold analysis and offer a rationale for the slope
or mL/min/1.73 m2 of GFR [4, 16].or threshold definition. A slope analysis is probably more
Using actual body weight in the Cockcroft-Gault equa-suitable when investigating risk factors for loss of renal
tion, however, overestimates the CCr of obese patients.function. The usual accompanying assumption of contin-
(Some have advocated substituting lean body weight intoued linear loss of renal function must be acknowledged.
the Cockcroft-Gault equation [25, 46], but lean bodyA threshold analysis may be more informative from
weight data are not commonly available.)a public health perspective since the adverse conse-
quences of CRI appear to be limited to those whose re- Of equal importance, if obesity rather than renal func-
nal function falls below a certain threshold. For example, tion was associated with the outcome of interest, using
compared with those with CCr 80 mL/min, a significant actual weight in the Cockcroft-Gault equation might in-
decrease in serum hematocrit was detected only among troduce a spurious association between renal function
women when CCr fell 40 mL/min [4]. Therefore, to and outcome.
accurately quantify the burden of disease associated with In general, we advocate that although age and sex are
mild to moderate CRI, threshold analyses are useful to used to estimate the Cockcroft-Gault CCr and the MDRD
determine the incidence rate and characteristics of new GFR, age and sex should still be adjusted for in the
“cases.” The cutoffs in these threshold analyses should multivariable models simultaneously. This is because age
be determined based on whether patients above and and sex themselves may be associated with the outcome.
below the threshold have distinct risks for some impor- Doing this, therefore, should give a less confounded esti-
tant outcome. mate of the effect of renal insufficiency on the outcome.
In observational studies, when it is possible that the
Interpreting the coefficients for age and sex under these
exposed and unexposed groups differ in ways other than
circumstances requires care, however, since they reflectby the factor of interest (such as creatinine generation),
not only the independent association between age, sexcareful analysis of and adjustment for baseline character-
and the outcome, but also biases in the estimating equa-istics is required.
tion. These biases may be different in different studies
depending on how patients were selected and the nature
EXAMINING MILD TO MODERATE CHRONIC of confounding.
RENAL INSUFFICIENCY AS AN EXPOSURE We favor using the Cockcroft-Gault CCr or the MDRD
Defining renal insufficiency as an exposure in a GFR as the measure of renal function in multivariable
multivariable analysis analyses. Parallel analyses with models using SCr and
containing terms for non-GFR determinants of SCr alsoTwo approaches have typically been adopted in large-
could be undertaken and the results compared. In allscale observational studies that divided patients into dif-
cases, assumptions of linearity should be explored by theferent categories of CRI to explore whether outcomes vary
use of polynomial terms and of unbiased categories, suchby category of renal function using multivariable analysis.
Using serum creatinine to classify renal function. This as 10 mL/min increments of CCr.
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To normalize or not to normalize cipients has been associated with accelerated graft loss,
presumably as a result of the functional demands on theThe Cockcroft-Gault equation estimates CCr in mL/
transplanted kidney exceeding its capacity for adaptationmin. The MDRD equations estimates GFR normalized
[57]. This leads to the interesting question of whetherto body surface area (BSA) as mL/min/1.73 m2.
body size, and perhaps other patient characteristics, mayThere is currently no consensus regarding whether or
modify the association between an absolute level of re-not to normalize measures of renal function. Parameters
duced renal function and certain outcomes. Effect modi-that have been used in the literature include: estimated
fication here refers to the fact that in different popula-absolute CCr [16], estimated CCr normalized to BSA (ab-
tions, the same absolute decreased GFR has differentstract; Wei GL et al, J Am Soc Nephrol 9:162A, 1998),
consequences.measured absolute CCr [47], measured CCr normalized to
For example, female and elderly subjects have on aver-body weight [8], measured CCr normalized to BSA [7],
age smaller body sizes and lower metabolic demands.measured absolute GFR [48], measured GFR normal-
At the same time, women on average have lower abso-ized to BSA [5], and estimated GFR normalized to BSA
lute GFR [58] and there is an “age-associated” CCr de-[49].
cline of 0.8 mL/min/year [59]. Given these observations,How should differences in body size be taken into
it is reasonable to ask whether women and elderly pa-account? One rationale for indexing GFR is that the
tients “need” less renal function. In other words, givenweight of the kidney and the basal metabolic rate are
the same absolute GFR of 30 mL/min, does this level ofproportional to BSA in normal individuals [50]. How-
renal insufficiency confer a higher risk of an adverseever, there is little research into whether BSA is the
outcome in a man than a women, or in a younger thanbest indexing parameter and some investigators have
an older person?advocated indexing to height [51] or to metabolic rate,
This hypothesis is supported by our recent finding thatwhich is proportional to (body mass)0.75 [52]. Others ar-
hematocrit decreased progressively when the Cockcroft-gue that a regression approach is preferable to indexing,
Gault CCr fell below 60 mL/min in men but not until itsince there is no need to assume that GFR increases as
was below 40 mL/min in women [4]. In other words, a CCra linear function of BSA and the intercept of this linear
of 50 mL/min is associated with adverse hematologicalfunction is zero [53].
effects in men but not in women. In this example, genderIt is unclear whether indexing GFR to BSA will under-
is an effect modifier of the relationship between renalestimate renal function in obese individuals. There are
insufficiency and anemia.conflicting data as to whether obese individuals have
We conclude that, in addition to considering demo-higher absolute GFR [51, 54, 55]. Normalizing to BSA
graphic variables as potential confounders of the associa-may introduce spurious associations if BSA, but not ab-
tion between mild to moderate CRI and the outcome,solute GFR, were associated with the outcome of inter-
these covariates should also be considered as potentialest. For example, indexing to BSA may distort the ob-
effect modifiers.served association between mild to moderate CRI and
outcomes positively associated with obesity, such as myo-
Implications for enrollment and follow-up of CRIcardial infarction.
cohort studiesFrom an epidemiological perspective, the best ratio-
The fact that in different populations, the same degreenale for taking body size differences into consideration
of reduced renal function may have different conse-when measuring kidney function would be if doing so
quences should inform the design and analysis of cohortreduces the bias in assessing the relationship between
studies of CRI. As discussed earlier in the section “Ex-renal function and outcome. Investigators should be cau-
amining mild to moderate chronic renal insufficiency astious not to index to parameters related to the outcomes
an outcome,” “threshold” analysis cohort studies use aof interest [56]. It may be advisable to perform analyses
certain cutoff to define the development of CRI andusing both body size-indexed and non-body size-indexed
then compare the number of new cases in the exposedmeasures of renal function and compare the results [4].
and unexposed groups. We argue above that the cutoffs
Effect modification of the association between mild to in these threshold analyses should be determined based
moderate CRI and adverse outcomes on whether subjects above and below the threshold have
distinct risks for some important outcome. For example,There is an intuitive idea that smaller body size engen-
if studies consistently demonstrate that men suffer ad-ders lower “metabolic demand” and smaller individuals
verse consequences of CRI at a higher level of GFR than“need” less renal function. This construct is borne out
women, then researchers should consider setting differ-in cadaveric kidney transplantation where the trans-
ent GFR thresholds for men and women in studies ofplantation of pediatric kidneys or the kidneys of older
donors (with fewer functional nephrons) into larger re- CRI as an outcome.
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More studies are needed to determine whether and SUMMARY
how the same level of decreased renal function result in The methodological issues to be considered when
different consequences in different demographic and studying the epidemiology of mild to moderate CRI are
clinical subgroups. Studies of CRI as an exposure should outlined as they relate to (1) defining the prevalence of
inform the design and analysis of studies of CRI as an CRI, (2) examining CRI as an outcome, and (3) examin-
outcome. We advocate that disease and outcome defini- ing CRI as an exposure. These considerations are also
tions in epidemiological studies of CRI should be based important for physicians when diagnosing and treating
on clinical consequences of reduced renal function rather individual patients with mild to moderate CRI and for
than on arbitrary cutoffs applied across all groups. policy makers when defining the population and implica-
tions of mild to moderate CRI.Complex relationships between exposures,
Our proposed solutions to these methodological chal-confounders and intermediary variables
lenges are summarized in Table 1. As we enter an era
There may be complex pathophysiologic interactions of more intensive study of mild to moderate CRI, recog-
among CRI, adverse outcomes and co-existing clinical nition of the potential pitfalls outlined here should guide
conditions. Co-existing clinical conditions among patients investigators toward improving the quality of research
with moderate CRI include factors, such as advanced in this field.
age and diabetes mellitus, which are risk factors for both
CRI and adverse outcomes such as myocardial infarction. ACKNOWLEDGMENTS
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